Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis

(2016) B Bressler et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

(2015) Maria Theresa Arias et al.   Clinical Gastroenterology and Hepatology

Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis

(2014) Alessandro Armuzzi et al.   INFLAMMATORY BOWEL DISEASES

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy

(2014) K. Subramaniam et al.   INTERNAL MEDICINE JOURNAL

Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients

(2013) M. Sjöberg et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Infliximab in Steroid-dependent Ulcerative Colitis

(2013) Alessandro Armuzzi et al.   INFLAMMATORY BOWEL DISEASES

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

(2012) E. Rostholder et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

(2012) Christina Ha et al.   Clinical Gastroenterology and Hepatology

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

(2011) M. De Vos et al.   Journal of Crohns & Colitis

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study

(2010) A. Gustavsson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals

(2010) Christian Mortensen et al.   Journal of Crohns & Colitis

Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single center experience

(2010) Ane Søgaard Teisner et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice

(2009) Y. ZABANA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England

(2008) E. A. RUSSO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Episodic Infliximab treatment induces infusion reactions

(2008) F. Margo et al.   INFLAMMATORY BOWEL DISEASES

Long-term outcome after infliximab for refractory ulcerative colitis

(2008) Marc Ferrante et al.   Journal of Crohns & Colitis

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

(2008) Inger Camilla Solberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY